Brittany Craiglow, MD
Dermatology, Pediatric Dermatology
Biography
Brittany Craiglow, MD, is a pediatric dermatologist and a leading expert in how alopecia areata, a chronic skin condition that causes hair loss, negatively affects health and quality of life in young patients. “It’s a devastating disorder. Having hair, eyebrows and eyelashes—these are all things most of us take for granted,” she says.
Research done by Dr. Craiglow and her colleagues has shown that people with alopecia areata are 39 percent more likely to develop generalized anxiety disorder or a major depressive disorder in their lifetimes.
Dr. Craiglow, who sees children and adolescent patients at Middlebury Dermatology and Yale Medicine Dermatology Associates in New Haven, has published research in leading medical journals on the effectiveness of a class of therapies called Janus Kinase (JAK) inhibitors for alopecia areata and associated disorders.
Titles
- Associate Professor Adjunct - Dermatology
Education & Training
- FellowshipYale University School of Medicine (2014)
- ResidencyYale-New Haven Hospital (2013)
- MDYale University School of Medicine (2009)
- BAYale University (2004)
Additional Information
Board Certifications
- AB of Dermatology, Pediatric Dermatology (2014)
- AB of Dermatology, Dermatology (2013)
Publications
- Ogbutor C, Chen L, Kalil L, Kelley K, Craiglow B, King B, Senna M. Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series. International Journal Of Women's Dermatology 2025, 11: e218. PMID: 40810112, PMCID: PMC12348381, DOI: 10.1097/jw9.0000000000000218.
- Craiglow B, Senna M, Mesinkovska N, Harshaw Q, Deering K, Shaikh A, Barghout V, Cassella J, Ferro T. 62923 Patient Preferences for the Treatment of Alopecia Areata. Journal Of The American Academy Of Dermatology 2025, 93: ab68. DOI: 10.1016/j.jaad.2025.05.274.
- Mostaghimi A, Mayo T, Craiglow B, Goh C, Murage M, Ball S, Dabbous F, Kawata A, Somani N, Tosti A. 61346 Baseline Psychosocial Impact of Disease in Patients with Severe Alopecia Areata Treated with Baricitinib Recruited from the US Customer Support Program. Journal Of The American Academy Of Dermatology 2025, 93: ab132. DOI: 10.1016/j.jaad.2025.05.531.
- Senna M, Craiglow B, Malley W, Wahl P, McLean R, King B. 65063 Characterization of treatment, disease burden, and patient-reported outcome measures in a real-world cohort of patients with alopecia areata: the CorEvitas Alopecia Areata Registry. Journal Of The American Academy Of Dermatology 2025, 93: ab144. DOI: 10.1016/j.jaad.2025.05.576.
- Meah N, Li J, Wall D, York K, Bhoyrul B, Bokhari L, Coulthard L, Asfour L, Abraham L, Asz‐Sigall D, Bergfeld W, Betz R, Blume‐Peytavi U, Callender V, Chitreddy V, Combalia A, Cotsarelis G, Craiglow B, Dhurat R, Dlova N, Donovan J, Doroshkevich A, Eisman S, Farrant P, Gadzhigoroeva A, Green J, Grimalt R, Harries M, Hordinsky M, Irvine A, Jolliffe V, Kaiumov S, King B, Kossard S, Lee J, Lee W, Lortkipanidze N, McMichael A, Mesinkovska N, Messenger A, Mirmirani P, Olsen E, Orlow S, Ovcharenko Y, Piraccini B, Pirmez R, Rakowska A, Reygagne P, Roberts J, Rudnicka L, Saceda‐Corralo D, Shapiro J, Sharma P, Silyuk T, Suchonwanit P, Takwale A, Tosti A, Visser W, Vañó‐Galván S, Vogt A, Wade M, Yip L, Zlotogorski A, Zhou C, Sinclair R. Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024. Journal Of The European Academy Of Dermatology And Venereology 2025 PMID: 40698981, DOI: 10.1111/jdv.20833.
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair SpecialistsO'Connor C, Boyle A, Asfour L, Bhoyrul B, Bokhari L, Cotsarelis G, Cotter C, Craiglow B, Cutlar L, Dhurat R, Dlova N, Doche I, Donovan J, Drucker A, Eisman S, Melo D, Harries M, Hordinsky M, Kazmi A, King B, Kolios A, Meah N, Mirmirani P, Mostaghimi A, Ohyama M, Ovcharenko Y, Pirmez R, Piraccini B, Rudnicka L, Saceda‐Corralo D, Shapiro J, Sibbald C, Sinclair R, Smith B, Starace M, Vaño‐Galván S, Koh W, York K, McDonald I, Wall D. COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists. JEADV Clinical Practice 2025, 4: 811-820. DOI: 10.1002/jvc2.70067.
- Valido K, Craiglow B. Baricitinib and oral minoxidil for the treatment of alopecia areata in pediatric patients. Journal Of The American Academy Of Dermatology 2025, 93: 509-510. PMID: 40185280, DOI: 10.1016/j.jaad.2025.03.085.
- Mostaghimi A, Craiglow B, King B, Shapiro J, Ko J, Tosti A, Ohyama M, Brogan Y, Yu G, Sontag A, Somani N. Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib. British Journal Of Dermatology 2025, 193: 240-249. PMID: 40179237, DOI: 10.1093/bjd/ljaf088.
- Kalil L, Welch D, Heath C, Craiglow B. Systemic Therapies for Pediatric Alopecia Areata. Pediatric Dermatology 2025, 42: 36-42. PMID: 40044621, DOI: 10.1111/pde.15822.
- Craiglow B. Guest Editor's Note. Pediatric Dermatology 2025, 42: 4-4. PMID: 40044618, DOI: 10.1111/pde.15861.
- Blume-Peytavi U, Craiglow B, Netravali I, Doche I, Harada K, Wajsbrot D, Bonfanti G, Ishowo-Adejumo R, Wolk R, Tran H. 125: Individual Severity of Alopecia Tool (SALT) score trajectories of roll-over adolescent patients with alopecia areata (AA) treated with ritlecitinib in the ongoing long-term, open-label, phase 3 ALLEGRO-LT study. Journal Of Investigative Dermatology 2025, 145: e30. DOI: 10.1016/j.jid.2025.02.128.
- Senna M, Taylor S, Piraccini B, Shapiro J, Somani N, Jedynak J, Ogwu S, Buchanan A, Craiglow B, Ohyama M. Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials. SKIN The Journal Of Cutaneous Medicine 2025, 9: s522. DOI: 10.25251/skin.9.supp.522.
- Akiska Y, Mirmirani P, Roseborough I, Mathes E, Bhutani T, Ambrosy A, Aguh C, Bergfeld W, Callender V, Castelo-Soccio L, Cotsarelis G, Craiglow B, Desai N, Doche I, Duque-Estrada B, Elston D, Goh C, Goldberg L, Grimalt R, Jabbari A, Jolliffe V, King B, LaSenna C, Lenzy Y, Lester J, Lortkipanidze N, Sicco K, McMichael A, Meah N, Mesinkovska N, Miteva M, Mostaghimi A, Ovcharenko Y, Piliang M, Piraccini B, Rakowska A, Salkey K, Schmidt A, Shapiro J, Sibbald C, Sinclair R, Suchonwanit P, Taylor S, Tosti A, Vañó-Galván S, Wall D, Fu J. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss. JAMA Dermatology 2025, 161: 87-95. PMID: 39565602, DOI: 10.1001/jamadermatol.2024.4593.
- Vleugels R, Craiglow B, Mostaghimi A, Olsen E, Sontag A, Denning K, Somani N, Hordinsky M. Worldwide Clinical and Real-World Exposure to Baricitinib. SKIN The Journal Of Cutaneous Medicine 2024, 8: s501. DOI: 10.25251/skin.8.supp.501.
- Simpson E, Siri D, Chovatiya R, Shahriari M, Burnette A, Craiglow B, Brown P, Tallman A. Achievement of No-to-minimal Itch and Sleep Improvement with Tapinarof Cream 1% Once Daily in Two Pivotal Phase 3 Trials in Adults and Children Down to 2 Years of Age with Atopic Dermatitis. SKIN The Journal Of Cutaneous Medicine 2024, 8: s459. DOI: 10.25251/skin.8.supp.459.
- Simpson E, Siri D, Chovatiya R, Shahriari M, Burnette A, Craiglow B, Brown P, Tallman A. ACHIEVEMENT OF ITCH-FREE STATE AND SLEEP IMPROVEMENT WITH TAPINAROF IN TWO PIVOTAL ATOPIC DERMATITIS TRIALS. Annals Of Allergy Asthma & Immunology 2024, 133: s9. DOI: 10.1016/j.anai.2024.08.055.
- Craiglow B, Lee Y, Vañó-Galván S, Egeberg A, Dutronc Y, Durand F, Pierce E, Yu G, Chen Y, Mostaghimi A. Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib. Dermatology And Therapy 2024, 14: 3193-3193. PMID: 39404927, PMCID: PMC11557806, DOI: 10.1007/s13555-024-01265-2.
- BH04 A global survey to assess practice of laboratory testing in alopecia areata by hair specialistsO’Connor C, Asfour L, Bokhari L, Cotsarelis G, Cotter C, Craiglow B, Cutlar L, Dhurat R, Dlova N, Doche I, Donovan J, Eisman S, Melo D, Harries M, Hordinsky M, Kazmi A, King B, Meah N, Ohyama M, Ovcharenko J, Primez R, Piraccini B, Rudnicka L, Corralo D, Shapiro J, Sinclair R, Smith B, Starace M, Galvan S, Wang K, York K, McDonald I, Wall D. BH04 A global survey to assess practice of laboratory testing in alopecia areata by hair specialists. British Journal Of Dermatology 2024, 191: i74-i75. DOI: 10.1093/bjd/ljae090.151.
- Craiglow B, Lee Y, Vañó-Galván S, Egeberg A, Dutronc Y, Durand F, Pierce E, Yu G, Chen Y, Mostaghimi A. Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib. Dermatology And Therapy 2024, 14: 1959-1968. PMID: 38904749, PMCID: PMC11265044, DOI: 10.1007/s13555-024-01208-x.
- Group A, Moussa A, Bennett M, Wall D, Meah N, York K, Bokhari L, Asfour L, Rees H, Abraham L, Asz-Sigall D, Basmanav F, Bergfeld W, Betz R, Bhoyrul B, Blume-Peytavi U, Callender V, Chitreddy V, Combalia A, Cotsarelis G, Craiglow B, Dhurat R, Donovan J, Doroshkevich A, Eisman S, Farrant P, Ferrando J, Gadzhigoroeva A, Green J, Grimalt R, Harries M, Hordinsky M, Irvine A, Jolliffe V, Kaiumov S, King B, Lee J, Lee W, Li J, Lortkipanidze N, McMichael A, Mesinkovska N, Messenger A, Mirmirani P, Olsen E, Orlow S, Ovcharenko Y, Piraccini B, Pirmez R, Rakowska A, Reygagne P, Rudnicka L, Corralo D, Senna M, Shapiro J, Sharma P, Siliuk T, Starace M, Suchonwanit P, Takwale A, Tosti A, Vañó-Galván S, Visser W, Vogt A, Wade M, Yip L, Zhou C, Sinclair R. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study. JAMA Dermatology 2024, 160: 341-350. PMID: 38324292, DOI: 10.1001/jamadermatol.2023.5869.
- Echeandia‐Francis C, Sun Q, Asch S, Bayart C, Benjamin L, Cipriano S, Craiglow B, Dyer J, Levy M, Lilly E, Newell B, Liang J, Gan G, Deng Y, Paller A, Choate K. In‐person validation of the Ichthyosis Scoring System. Pediatric Dermatology 2024, 41: 247-252. PMID: 38234066, DOI: 10.1111/pde.15508.
- Mayo T, Taylor S, Ito T, Vañó-Galván S, Ball S, Lu N, Chiasserini C, Chen Y, Craiglow B, Leveque C. Efficacité dans les sous-groupes liée aux caractéristiques de la maladie de patients atteints de pelade dans les études BRAVE-AA1 et BRAVE-AA2. Annales De Dermatologie Et De Vénéréologie - FMC 2023, 3: a336. DOI: 10.1016/j.fander.2023.09.579.
- Piraccini B, Ohyama M, Craiglow B, Bewley A, Ding Y, Chen Y, Dutronc Y, Pierce E, Durand F, Mostaghimi A. Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials. JEADV Clinical Practice 2023, 3: 242-248. DOI: 10.1002/jvc2.269.
- King B, Shapiro J, Ohyama M, Egeberg A, Piraccini B, Craiglow B, Sinclair R, Chen Y, Wu W, Ding Y, Somani N, Dutronc Y. When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials. British Journal Of Dermatology 2023, 189: 666-673. PMID: 37708254, DOI: 10.1093/bjd/ljad253.
- Craiglow B, Lee Y, Vañó-Galván S, Egeberg A, Dutronc Y, Durand F, Pierce E, Ding Y, Chen Y, Mostaghimi A. 41915 Improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata achieving scalp hair regrowth: results from two randomized controlled trials. Journal Of The American Academy Of Dermatology 2023, 89: ab55. DOI: 10.1016/j.jaad.2023.07.224.
- Shapiro J, Ko J, Egeberg A, Somani N, Jedynak J, Torisu-Itakura H, Yu G, Lu N, Craiglow B. 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata. Journal Of The American Academy Of Dermatology 2023, 89: ab127. DOI: 10.1016/j.jaad.2023.07.511.
- Mayo T, Taylor S, Ito T, Galván S, Ball S, Lu N, Chiasserinio C, Chen Y, Craiglow B. 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2. Journal Of The American Academy Of Dermatology 2023, 89: ab42. DOI: 10.1016/j.jaad.2023.07.173.
- Ko J, Mayo T, Bergfeld W, Dutronc Y, Yu G, Ball S, Somani N, Craiglow B. Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata. JAMA Dermatology 2023, 159: 970-976. PMID: 37556146, PMCID: PMC10413213, DOI: 10.1001/jamadermatol.2023.2581.
- King B, Craiglow B. Janus kinase inhibitors for alopecia areata. Journal Of The American Academy Of Dermatology 2023, 89: s29-s32. PMID: 37591562, DOI: 10.1016/j.jaad.2023.05.049.
- Piraccini B, Ohyama M, Craiglow B, Bewley A, Ding Y, Chen Y, Dutronc Y, Pierce E, Durand F, Mostaghimi A. Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials. Journal Of Dermatological Treatment 2023, 34: 2227299. PMID: 37381691, DOI: 10.1080/09546634.2023.2227299.
- Mesinkovska N, Craiglow B, Ball S, Morrow P, Smith S, Pierce E, Shapiro J. The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata. Dermatology And Therapy 2023, 13: 1503-1515. PMID: 37289409, PMCID: PMC10307747, DOI: 10.1007/s13555-023-00941-z.
- Piraccini B, Ohyama M, Craiglow B, Bewley A, Ding Y, Chen Y, Dutronc Y, Pierce E, Durand F, Mostaghimi A. Scalp Hair Regrowth Is Associated With Improvements in Health-Related Quality of Life and Psychological Symptoms in Patients With Severe Alopecia Areata: Results From Two Randomized Controlled Trials. SKIN The Journal Of Cutaneous Medicine 2023, 7: s186. DOI: 10.25251/skin.7.supp.186.
- Sun Q, Marukian N, Cheraghlou S, Paller A, Larralde M, Bercovitch L, Levinsohn J, Ren I, Hu R, Zhou J, Zaki T, Fan R, Tian C, Saraceni C, Nelson-Williams C, Loring E, Craiglow B, Milstone L, Lifton R, Boyden L, Choate K. 502 The genomic and phenotypic landscape of ichthyosis: An analysis of 1000 kindreds. Journal Of Investigative Dermatology 2022, 142: s85. DOI: 10.1016/j.jid.2022.05.511.
- Wambier C, Craiglow B, King B. Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK. Surgical & Cosmetic Dermatology 2020, 12 DOI: 10.5935/scd1984-8773.20201211512.
- Ko CJ, Atzmony L, Lim Y, McNiff JM, Craiglow B, Antaya RJ, Choate KA. Review of genodermatoses with characteristic histopathology and potential diagnostic delay. Journal Of Cutaneous Pathology 2019, 46: 756-765. PMID: 31148225, DOI: 10.1111/cup.13520.
- Olamiju B, Ren I, Li L, Deng Y, Marukian N, Zhou J, Hu R, Zaki T, Craiglow B, Choate K. 379 Quality of life in children with ichthyosis. Journal Of Investigative Dermatology 2018, 138: s64. DOI: 10.1016/j.jid.2018.03.385.
- Mauldin E, Cassal M, Jeong S, Vavrova K, Uchida Y, Park K, Craiglow B, Choate K, Shin K, Lee Y, Khnykin D, Grove G, Elias P. 458 Cellular and metabolic basis for the ichthyotic phenotype in ichthyin deficiency. Journal Of Investigative Dermatology 2017, 137: s79. DOI: 10.1016/j.jid.2017.02.477.
- Marukian N, Deng Y, Gan G, Ren I, Thermidor W, Craiglow B, Milstone L, Choate K. 291 Establishing and validating an ichthyosis severity index. Journal Of Investigative Dermatology 2017, 137: s50. DOI: 10.1016/j.jid.2017.02.307.
- Boyden L, Kam C, Hernández-Martín A, Zhou J, Craiglow B, Milstone L, Hu R, Elias P, Green K, Choate K. 383 A novel erythrokeratodermia-cardiomyopathy syndrome is caused by dominant, clustered mutations in desmoplakin. Journal Of Investigative Dermatology 2016, 136: s68. DOI: 10.1016/j.jid.2016.02.416.
- Boyden LM, Craiglow BG, Zhou J, Hu R, Loring EC, Morel KD, Lauren CT, Lifton RP, Bilguvar K, Paller A, Choate K. Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia. Journal Of Investigative Dermatology 2014, 135: 1540-1547. PMID: 25398053, PMCID: PMC4430428, DOI: 10.1038/jid.2014.485.
- Craiglow BG, King BA. Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis. Journal Of Investigative Dermatology 2014, 134: 2988-2990. PMID: 24940651, DOI: 10.1038/jid.2014.260.
- Levinsohn JL, Teng J, Craiglow BG, Loring EC, Burrow TA, Mane SS, Overton JD, Lifton RP, McNiff JM, Lucky AW, Choate KA. Somatic HRAS p.G12S Mutation Causes Woolly Hair and Epidermal Nevi. Journal Of Investigative Dermatology 2013, 134: 1149-1152. PMID: 24129065, PMCID: PMC3961553, DOI: 10.1038/jid.2013.430.
- Craiglow BG, Choate KA, Milstone LM. Topical Tazarotene for the Treatment of Ectropion in Ichthyosis. JAMA Dermatology 2013, 149: 598-600. PMID: 23677086, PMCID: PMC3809825, DOI: 10.1001/jamadermatol.2013.239.
- Craiglow BG, Ko CJ, Antaya RJ. Two Cases of Hemihyperplasia–Multiple Lipomatosis Syndrome and Review of Asymmetric Hemihyperplasia Syndromes. Pediatric Dermatology 2013, 31: 507-510. PMID: 23458125, DOI: 10.1111/pde.12071.
- Craiglow BG, Antaya RJ. Management of Infantile Hemangiomas. Pediatric Drugs 2013, 15: 133-138. PMID: 23456550, DOI: 10.1007/s40272-013-0008-6.
- Craiglow BG. Ichthyosis in the newborn. Seminars In Perinatology 2013, 37: 26-31. PMID: 23419760, PMCID: PMC3758581, DOI: 10.1053/j.semperi.2012.11.001.
- Craiglow BG, Resneck JS, Lucky AW, Sidbury R, Yan AC, Resnick SD, Antaya RJ. Pediatric dermatology workforce shortage: Perspectives from academia. Journal Of The American Academy Of Dermatology 2008, 59: 986-989. PMID: 18835061, DOI: 10.1016/j.jaad.2008.08.036.
Departments and Programs
Biography
Brittany Craiglow, MD, is a pediatric dermatologist and a leading expert in how alopecia areata, a chronic skin condition that causes hair loss, negatively affects health and quality of life in young patients. “It’s a devastating disorder. Having hair, eyebrows and eyelashes—these are all things most of us take for granted,” she says.
Research done by Dr. Craiglow and her colleagues has shown that people with alopecia areata are 39 percent more likely to develop generalized anxiety disorder or a major depressive disorder in their lifetimes.
Dr. Craiglow, who sees children and adolescent patients at Middlebury Dermatology and Yale Medicine Dermatology Associates in New Haven, has published research in leading medical journals on the effectiveness of a class of therapies called Janus Kinase (JAK) inhibitors for alopecia areata and associated disorders.
Titles
- Associate Professor Adjunct - Dermatology
Education & Training
- FellowshipYale University School of Medicine (2014)
- ResidencyYale-New Haven Hospital (2013)
- MDYale University School of Medicine (2009)
- BAYale University (2004)
Additional Information
Board Certifications
- AB of Dermatology, Pediatric Dermatology (2014)
- AB of Dermatology, Dermatology (2013)
Publications
- Ogbutor C, Chen L, Kalil L, Kelley K, Craiglow B, King B, Senna M. Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series. International Journal Of Women's Dermatology 2025, 11: e218. PMID: 40810112, PMCID: PMC12348381, DOI: 10.1097/jw9.0000000000000218.
- Craiglow B, Senna M, Mesinkovska N, Harshaw Q, Deering K, Shaikh A, Barghout V, Cassella J, Ferro T. 62923 Patient Preferences for the Treatment of Alopecia Areata. Journal Of The American Academy Of Dermatology 2025, 93: ab68. DOI: 10.1016/j.jaad.2025.05.274.
- Mostaghimi A, Mayo T, Craiglow B, Goh C, Murage M, Ball S, Dabbous F, Kawata A, Somani N, Tosti A. 61346 Baseline Psychosocial Impact of Disease in Patients with Severe Alopecia Areata Treated with Baricitinib Recruited from the US Customer Support Program. Journal Of The American Academy Of Dermatology 2025, 93: ab132. DOI: 10.1016/j.jaad.2025.05.531.
- Senna M, Craiglow B, Malley W, Wahl P, McLean R, King B. 65063 Characterization of treatment, disease burden, and patient-reported outcome measures in a real-world cohort of patients with alopecia areata: the CorEvitas Alopecia Areata Registry. Journal Of The American Academy Of Dermatology 2025, 93: ab144. DOI: 10.1016/j.jaad.2025.05.576.
- Meah N, Li J, Wall D, York K, Bhoyrul B, Bokhari L, Coulthard L, Asfour L, Abraham L, Asz‐Sigall D, Bergfeld W, Betz R, Blume‐Peytavi U, Callender V, Chitreddy V, Combalia A, Cotsarelis G, Craiglow B, Dhurat R, Dlova N, Donovan J, Doroshkevich A, Eisman S, Farrant P, Gadzhigoroeva A, Green J, Grimalt R, Harries M, Hordinsky M, Irvine A, Jolliffe V, Kaiumov S, King B, Kossard S, Lee J, Lee W, Lortkipanidze N, McMichael A, Mesinkovska N, Messenger A, Mirmirani P, Olsen E, Orlow S, Ovcharenko Y, Piraccini B, Pirmez R, Rakowska A, Reygagne P, Roberts J, Rudnicka L, Saceda‐Corralo D, Shapiro J, Sharma P, Silyuk T, Suchonwanit P, Takwale A, Tosti A, Visser W, Vañó‐Galván S, Vogt A, Wade M, Yip L, Zlotogorski A, Zhou C, Sinclair R. Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024. Journal Of The European Academy Of Dermatology And Venereology 2025 PMID: 40698981, DOI: 10.1111/jdv.20833.
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair SpecialistsO'Connor C, Boyle A, Asfour L, Bhoyrul B, Bokhari L, Cotsarelis G, Cotter C, Craiglow B, Cutlar L, Dhurat R, Dlova N, Doche I, Donovan J, Drucker A, Eisman S, Melo D, Harries M, Hordinsky M, Kazmi A, King B, Kolios A, Meah N, Mirmirani P, Mostaghimi A, Ohyama M, Ovcharenko Y, Pirmez R, Piraccini B, Rudnicka L, Saceda‐Corralo D, Shapiro J, Sibbald C, Sinclair R, Smith B, Starace M, Vaño‐Galván S, Koh W, York K, McDonald I, Wall D. COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists. JEADV Clinical Practice 2025, 4: 811-820. DOI: 10.1002/jvc2.70067.
- Valido K, Craiglow B. Baricitinib and oral minoxidil for the treatment of alopecia areata in pediatric patients. Journal Of The American Academy Of Dermatology 2025, 93: 509-510. PMID: 40185280, DOI: 10.1016/j.jaad.2025.03.085.
- Mostaghimi A, Craiglow B, King B, Shapiro J, Ko J, Tosti A, Ohyama M, Brogan Y, Yu G, Sontag A, Somani N. Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib. British Journal Of Dermatology 2025, 193: 240-249. PMID: 40179237, DOI: 10.1093/bjd/ljaf088.
- Kalil L, Welch D, Heath C, Craiglow B. Systemic Therapies for Pediatric Alopecia Areata. Pediatric Dermatology 2025, 42: 36-42. PMID: 40044621, DOI: 10.1111/pde.15822.
- Craiglow B. Guest Editor's Note. Pediatric Dermatology 2025, 42: 4-4. PMID: 40044618, DOI: 10.1111/pde.15861.
- Blume-Peytavi U, Craiglow B, Netravali I, Doche I, Harada K, Wajsbrot D, Bonfanti G, Ishowo-Adejumo R, Wolk R, Tran H. 125: Individual Severity of Alopecia Tool (SALT) score trajectories of roll-over adolescent patients with alopecia areata (AA) treated with ritlecitinib in the ongoing long-term, open-label, phase 3 ALLEGRO-LT study. Journal Of Investigative Dermatology 2025, 145: e30. DOI: 10.1016/j.jid.2025.02.128.
- Senna M, Taylor S, Piraccini B, Shapiro J, Somani N, Jedynak J, Ogwu S, Buchanan A, Craiglow B, Ohyama M. Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials. SKIN The Journal Of Cutaneous Medicine 2025, 9: s522. DOI: 10.25251/skin.9.supp.522.
- Akiska Y, Mirmirani P, Roseborough I, Mathes E, Bhutani T, Ambrosy A, Aguh C, Bergfeld W, Callender V, Castelo-Soccio L, Cotsarelis G, Craiglow B, Desai N, Doche I, Duque-Estrada B, Elston D, Goh C, Goldberg L, Grimalt R, Jabbari A, Jolliffe V, King B, LaSenna C, Lenzy Y, Lester J, Lortkipanidze N, Sicco K, McMichael A, Meah N, Mesinkovska N, Miteva M, Mostaghimi A, Ovcharenko Y, Piliang M, Piraccini B, Rakowska A, Salkey K, Schmidt A, Shapiro J, Sibbald C, Sinclair R, Suchonwanit P, Taylor S, Tosti A, Vañó-Galván S, Wall D, Fu J. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss. JAMA Dermatology 2025, 161: 87-95. PMID: 39565602, DOI: 10.1001/jamadermatol.2024.4593.
- Vleugels R, Craiglow B, Mostaghimi A, Olsen E, Sontag A, Denning K, Somani N, Hordinsky M. Worldwide Clinical and Real-World Exposure to Baricitinib. SKIN The Journal Of Cutaneous Medicine 2024, 8: s501. DOI: 10.25251/skin.8.supp.501.
- Simpson E, Siri D, Chovatiya R, Shahriari M, Burnette A, Craiglow B, Brown P, Tallman A. Achievement of No-to-minimal Itch and Sleep Improvement with Tapinarof Cream 1% Once Daily in Two Pivotal Phase 3 Trials in Adults and Children Down to 2 Years of Age with Atopic Dermatitis. SKIN The Journal Of Cutaneous Medicine 2024, 8: s459. DOI: 10.25251/skin.8.supp.459.
- Simpson E, Siri D, Chovatiya R, Shahriari M, Burnette A, Craiglow B, Brown P, Tallman A. ACHIEVEMENT OF ITCH-FREE STATE AND SLEEP IMPROVEMENT WITH TAPINAROF IN TWO PIVOTAL ATOPIC DERMATITIS TRIALS. Annals Of Allergy Asthma & Immunology 2024, 133: s9. DOI: 10.1016/j.anai.2024.08.055.
- Craiglow B, Lee Y, Vañó-Galván S, Egeberg A, Dutronc Y, Durand F, Pierce E, Yu G, Chen Y, Mostaghimi A. Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib. Dermatology And Therapy 2024, 14: 3193-3193. PMID: 39404927, PMCID: PMC11557806, DOI: 10.1007/s13555-024-01265-2.
- BH04 A global survey to assess practice of laboratory testing in alopecia areata by hair specialistsO’Connor C, Asfour L, Bokhari L, Cotsarelis G, Cotter C, Craiglow B, Cutlar L, Dhurat R, Dlova N, Doche I, Donovan J, Eisman S, Melo D, Harries M, Hordinsky M, Kazmi A, King B, Meah N, Ohyama M, Ovcharenko J, Primez R, Piraccini B, Rudnicka L, Corralo D, Shapiro J, Sinclair R, Smith B, Starace M, Galvan S, Wang K, York K, McDonald I, Wall D. BH04 A global survey to assess practice of laboratory testing in alopecia areata by hair specialists. British Journal Of Dermatology 2024, 191: i74-i75. DOI: 10.1093/bjd/ljae090.151.
- Craiglow B, Lee Y, Vañó-Galván S, Egeberg A, Dutronc Y, Durand F, Pierce E, Yu G, Chen Y, Mostaghimi A. Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib. Dermatology And Therapy 2024, 14: 1959-1968. PMID: 38904749, PMCID: PMC11265044, DOI: 10.1007/s13555-024-01208-x.
- Group A, Moussa A, Bennett M, Wall D, Meah N, York K, Bokhari L, Asfour L, Rees H, Abraham L, Asz-Sigall D, Basmanav F, Bergfeld W, Betz R, Bhoyrul B, Blume-Peytavi U, Callender V, Chitreddy V, Combalia A, Cotsarelis G, Craiglow B, Dhurat R, Donovan J, Doroshkevich A, Eisman S, Farrant P, Ferrando J, Gadzhigoroeva A, Green J, Grimalt R, Harries M, Hordinsky M, Irvine A, Jolliffe V, Kaiumov S, King B, Lee J, Lee W, Li J, Lortkipanidze N, McMichael A, Mesinkovska N, Messenger A, Mirmirani P, Olsen E, Orlow S, Ovcharenko Y, Piraccini B, Pirmez R, Rakowska A, Reygagne P, Rudnicka L, Corralo D, Senna M, Shapiro J, Sharma P, Siliuk T, Starace M, Suchonwanit P, Takwale A, Tosti A, Vañó-Galván S, Visser W, Vogt A, Wade M, Yip L, Zhou C, Sinclair R. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study. JAMA Dermatology 2024, 160: 341-350. PMID: 38324292, DOI: 10.1001/jamadermatol.2023.5869.
- Echeandia‐Francis C, Sun Q, Asch S, Bayart C, Benjamin L, Cipriano S, Craiglow B, Dyer J, Levy M, Lilly E, Newell B, Liang J, Gan G, Deng Y, Paller A, Choate K. In‐person validation of the Ichthyosis Scoring System. Pediatric Dermatology 2024, 41: 247-252. PMID: 38234066, DOI: 10.1111/pde.15508.
- Mayo T, Taylor S, Ito T, Vañó-Galván S, Ball S, Lu N, Chiasserini C, Chen Y, Craiglow B, Leveque C. Efficacité dans les sous-groupes liée aux caractéristiques de la maladie de patients atteints de pelade dans les études BRAVE-AA1 et BRAVE-AA2. Annales De Dermatologie Et De Vénéréologie - FMC 2023, 3: a336. DOI: 10.1016/j.fander.2023.09.579.
- Piraccini B, Ohyama M, Craiglow B, Bewley A, Ding Y, Chen Y, Dutronc Y, Pierce E, Durand F, Mostaghimi A. Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials. JEADV Clinical Practice 2023, 3: 242-248. DOI: 10.1002/jvc2.269.
- King B, Shapiro J, Ohyama M, Egeberg A, Piraccini B, Craiglow B, Sinclair R, Chen Y, Wu W, Ding Y, Somani N, Dutronc Y. When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials. British Journal Of Dermatology 2023, 189: 666-673. PMID: 37708254, DOI: 10.1093/bjd/ljad253.
- Craiglow B, Lee Y, Vañó-Galván S, Egeberg A, Dutronc Y, Durand F, Pierce E, Ding Y, Chen Y, Mostaghimi A. 41915 Improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata achieving scalp hair regrowth: results from two randomized controlled trials. Journal Of The American Academy Of Dermatology 2023, 89: ab55. DOI: 10.1016/j.jaad.2023.07.224.
- Shapiro J, Ko J, Egeberg A, Somani N, Jedynak J, Torisu-Itakura H, Yu G, Lu N, Craiglow B. 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata. Journal Of The American Academy Of Dermatology 2023, 89: ab127. DOI: 10.1016/j.jaad.2023.07.511.
- Mayo T, Taylor S, Ito T, Galván S, Ball S, Lu N, Chiasserinio C, Chen Y, Craiglow B. 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2. Journal Of The American Academy Of Dermatology 2023, 89: ab42. DOI: 10.1016/j.jaad.2023.07.173.
- Ko J, Mayo T, Bergfeld W, Dutronc Y, Yu G, Ball S, Somani N, Craiglow B. Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata. JAMA Dermatology 2023, 159: 970-976. PMID: 37556146, PMCID: PMC10413213, DOI: 10.1001/jamadermatol.2023.2581.
- King B, Craiglow B. Janus kinase inhibitors for alopecia areata. Journal Of The American Academy Of Dermatology 2023, 89: s29-s32. PMID: 37591562, DOI: 10.1016/j.jaad.2023.05.049.
- Piraccini B, Ohyama M, Craiglow B, Bewley A, Ding Y, Chen Y, Dutronc Y, Pierce E, Durand F, Mostaghimi A. Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials. Journal Of Dermatological Treatment 2023, 34: 2227299. PMID: 37381691, DOI: 10.1080/09546634.2023.2227299.
- Mesinkovska N, Craiglow B, Ball S, Morrow P, Smith S, Pierce E, Shapiro J. The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata. Dermatology And Therapy 2023, 13: 1503-1515. PMID: 37289409, PMCID: PMC10307747, DOI: 10.1007/s13555-023-00941-z.
- Piraccini B, Ohyama M, Craiglow B, Bewley A, Ding Y, Chen Y, Dutronc Y, Pierce E, Durand F, Mostaghimi A. Scalp Hair Regrowth Is Associated With Improvements in Health-Related Quality of Life and Psychological Symptoms in Patients With Severe Alopecia Areata: Results From Two Randomized Controlled Trials. SKIN The Journal Of Cutaneous Medicine 2023, 7: s186. DOI: 10.25251/skin.7.supp.186.
- Sun Q, Marukian N, Cheraghlou S, Paller A, Larralde M, Bercovitch L, Levinsohn J, Ren I, Hu R, Zhou J, Zaki T, Fan R, Tian C, Saraceni C, Nelson-Williams C, Loring E, Craiglow B, Milstone L, Lifton R, Boyden L, Choate K. 502 The genomic and phenotypic landscape of ichthyosis: An analysis of 1000 kindreds. Journal Of Investigative Dermatology 2022, 142: s85. DOI: 10.1016/j.jid.2022.05.511.
- Wambier C, Craiglow B, King B. Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK. Surgical & Cosmetic Dermatology 2020, 12 DOI: 10.5935/scd1984-8773.20201211512.
- Ko CJ, Atzmony L, Lim Y, McNiff JM, Craiglow B, Antaya RJ, Choate KA. Review of genodermatoses with characteristic histopathology and potential diagnostic delay. Journal Of Cutaneous Pathology 2019, 46: 756-765. PMID: 31148225, DOI: 10.1111/cup.13520.
- Olamiju B, Ren I, Li L, Deng Y, Marukian N, Zhou J, Hu R, Zaki T, Craiglow B, Choate K. 379 Quality of life in children with ichthyosis. Journal Of Investigative Dermatology 2018, 138: s64. DOI: 10.1016/j.jid.2018.03.385.
- Mauldin E, Cassal M, Jeong S, Vavrova K, Uchida Y, Park K, Craiglow B, Choate K, Shin K, Lee Y, Khnykin D, Grove G, Elias P. 458 Cellular and metabolic basis for the ichthyotic phenotype in ichthyin deficiency. Journal Of Investigative Dermatology 2017, 137: s79. DOI: 10.1016/j.jid.2017.02.477.
- Marukian N, Deng Y, Gan G, Ren I, Thermidor W, Craiglow B, Milstone L, Choate K. 291 Establishing and validating an ichthyosis severity index. Journal Of Investigative Dermatology 2017, 137: s50. DOI: 10.1016/j.jid.2017.02.307.
- Boyden L, Kam C, Hernández-Martín A, Zhou J, Craiglow B, Milstone L, Hu R, Elias P, Green K, Choate K. 383 A novel erythrokeratodermia-cardiomyopathy syndrome is caused by dominant, clustered mutations in desmoplakin. Journal Of Investigative Dermatology 2016, 136: s68. DOI: 10.1016/j.jid.2016.02.416.
- Boyden LM, Craiglow BG, Zhou J, Hu R, Loring EC, Morel KD, Lauren CT, Lifton RP, Bilguvar K, Paller A, Choate K. Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia. Journal Of Investigative Dermatology 2014, 135: 1540-1547. PMID: 25398053, PMCID: PMC4430428, DOI: 10.1038/jid.2014.485.
- Craiglow BG, King BA. Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis. Journal Of Investigative Dermatology 2014, 134: 2988-2990. PMID: 24940651, DOI: 10.1038/jid.2014.260.
- Levinsohn JL, Teng J, Craiglow BG, Loring EC, Burrow TA, Mane SS, Overton JD, Lifton RP, McNiff JM, Lucky AW, Choate KA. Somatic HRAS p.G12S Mutation Causes Woolly Hair and Epidermal Nevi. Journal Of Investigative Dermatology 2013, 134: 1149-1152. PMID: 24129065, PMCID: PMC3961553, DOI: 10.1038/jid.2013.430.
- Craiglow BG, Choate KA, Milstone LM. Topical Tazarotene for the Treatment of Ectropion in Ichthyosis. JAMA Dermatology 2013, 149: 598-600. PMID: 23677086, PMCID: PMC3809825, DOI: 10.1001/jamadermatol.2013.239.
- Craiglow BG, Ko CJ, Antaya RJ. Two Cases of Hemihyperplasia–Multiple Lipomatosis Syndrome and Review of Asymmetric Hemihyperplasia Syndromes. Pediatric Dermatology 2013, 31: 507-510. PMID: 23458125, DOI: 10.1111/pde.12071.
- Craiglow BG, Antaya RJ. Management of Infantile Hemangiomas. Pediatric Drugs 2013, 15: 133-138. PMID: 23456550, DOI: 10.1007/s40272-013-0008-6.
- Craiglow BG. Ichthyosis in the newborn. Seminars In Perinatology 2013, 37: 26-31. PMID: 23419760, PMCID: PMC3758581, DOI: 10.1053/j.semperi.2012.11.001.
- Craiglow BG, Resneck JS, Lucky AW, Sidbury R, Yan AC, Resnick SD, Antaya RJ. Pediatric dermatology workforce shortage: Perspectives from academia. Journal Of The American Academy Of Dermatology 2008, 59: 986-989. PMID: 18835061, DOI: 10.1016/j.jaad.2008.08.036.
Departments and Programs